BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35315403)

  • 21. DNA Methylation and Transcription Patterns in Intestinal Epithelial Cells From Pediatric Patients With Inflammatory Bowel Diseases Differentiate Disease Subtypes and Associate With Outcome.
    Howell KJ; Kraiczy J; Nayak KM; Gasparetto M; Ross A; Lee C; Mak TN; Koo BK; Kumar N; Lawley T; Sinha A; Rosenstiel P; Heuschkel R; Stegle O; Zilbauer M
    Gastroenterology; 2018 Feb; 154(3):585-598. PubMed ID: 29031501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colonic expression of MUC2, MUC5AC, and TFF1 in inflammatory bowel disease in children.
    Shaoul R; Okada Y; Cutz E; Marcon MA
    J Pediatr Gastroenterol Nutr; 2004 May; 38(5):488-93. PubMed ID: 15097436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter methylation of the
    Klasić M; Markulin D; Vojta A; Samaržija I; Biruš I; Dobrinić P; Ventham NT; Trbojević-Akmačić I; Šimurina M; Štambuk J; Razdorov G; Kennedy NA; Satsangi J; Dias AM; Pinho S; Annese V; Latiano A; D'Inca R; ; Lauc G; Zoldoš V
    Clin Epigenetics; 2018; 10():75. PubMed ID: 29991969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Aberrant Promoter Methylation Changes in the Suppressor of Cytokine Signaling 3
    Sanati G; Jafari D; Noruzinia M; Ebrahimi Daryani N; Ahmadvand M; Teimourian S; Rezaei N
    Avicenna J Med Biotechnol; 2022; 14(2):165-169. PubMed ID: 35633985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trefoil Factor Family (TFF) Peptides and Their Diverse Molecular Functions in Mucus Barrier Protection and More: Changing the Paradigm.
    Hoffmann W
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trefoil factor family peptides TFF1 and TFF3 in the nervous tissues of developing mouse embryo.
    Belovari T; Bijelić N; Tolušić Levak M; Baus Lončar M
    Bosn J Basic Med Sci; 2015 Feb; 15(1):33-7. PubMed ID: 25725142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced expression of TFF1 and increased expression of TFF3 in gastric cancer: correlation with clinicopathological parameters and prognosis.
    Im S; Yoo C; Jung JH; Choi HJ; Yoo J; Kang CS
    Int J Med Sci; 2013; 10(2):133-40. PubMed ID: 23329884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Profiling trefoil factor family (TFF) expression in the mouse: identification of an antisense TFF1-related transcript in the kidney and liver.
    Hertel SC; Chwieralski CE; Hinz M; Rio MC; Tomasetto C; Hoffmann W
    Peptides; 2004 May; 25(5):755-62. PubMed ID: 15177869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased trefoil factor 3 levels in the serum of patients with three major histological subtypes of lung cancer.
    Qu Y; Yang Y; Ma D; Xiao W
    Oncol Rep; 2012 Apr; 27(4):1277-83. PubMed ID: 22246423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocyte nuclear factor 3 (winged helix domain) activates trefoil factor gene TFF1 through a binding motif adjacent to the TATAA box.
    Beck S; Sommer P; dos Santos Silva E; Blin N; Gött P
    DNA Cell Biol; 1999 Feb; 18(2):157-64. PubMed ID: 10073575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trefoil factors and human gastric cancer (review).
    Katoh M
    Int J Mol Med; 2003 Jul; 12(1):3-9. PubMed ID: 12792801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trefoil factors: tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma.
    Kosriwong K; Menheniott TR; Giraud AS; Jearanaikoon P; Sripa B; Limpaiboon T
    World J Gastroenterol; 2011 Mar; 17(12):1631-41. PubMed ID: 21472131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylation quantitative trait loci are largely consistent across disease states in Crohn's disease.
    Venkateswaran S; Somineni HK; Kilaru V; Katrinli S; Prince J; Okou DT; Hyams JS; Denson LA; Kellermayer R; Gibson G; Cutler DJ; Smith AK; Kugathasan S; Conneely KN
    G3 (Bethesda); 2022 Apr; 12(4):. PubMed ID: 35172000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trefoil factor 1 (TFF1) is a potential prognostic biomarker with functional significance in breast cancers.
    Yi J; Ren L; Li D; Wu J; Li W; Du G; Wang J
    Biomed Pharmacother; 2020 Apr; 124():109827. PubMed ID: 31986408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A functional polymorphism in TFF1 promoter is associated with the risk and prognosis of gastric cancer.
    Wang W; Li Z; Wang J; Du M; Li B; Zhang L; Li Q; Xu J; Wang L; Li F; Zhang D; Xu H; Yang L; Gong W; Qiang F; Zhang Z; Xu Z
    Int J Cancer; 2018 May; 142(9):1805-1816. PubMed ID: 29210057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues.
    Leung WK; Yu J; Chan FK; To KF; Chan MW; Ebert MP; Ng EK; Chung SC; Malfertheiner P; Sung JJ
    J Pathol; 2002 Aug; 197(5):582-8. PubMed ID: 12210076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant JAK/STAT Signaling Suppresses TFF1 and TFF2 through Epigenetic Silencing of GATA6 in Gastric Cancer.
    Wu CS; Wei KL; Chou JL; Lu CK; Hsieh CC; Lin JM; Deng YF; Hsu WT; Wang HM; Leung CH; Ma DL; Li C; Chan MW
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27598141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucosal gene expression changes induced by anti-TNF treatment in inflammatory bowel disease patients.
    Milanesi E; Dobre M; Manuc TE; Becheanu G; Tieranu CG; Ionescu EM; Manuc M
    Drug Dev Res; 2019 Sep; 80(6):831-836. PubMed ID: 31322753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of gastric carcinogenesis by the hormone gastrin is mediated by suppression of TFF1 epigenetic silencing.
    Tomita H; Takaishi S; Menheniott TR; Yang X; Shibata W; Jin G; Betz KS; Kawakami K; Minamoto T; Tomasetto C; Rio MC; Lerkowit N; Varro A; Giraud AS; Wang TC
    Gastroenterology; 2011 Mar; 140(3):879-91. PubMed ID: 21111741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-Benefit Analysis of the Introduction of Mp-Mri Guided Biopsies in Croatia.
    Pezelj I; Tomašković I; Bolanča Čulo K; Novosel L; Tomić M; Reljić A; Katušić J; Knežević M; Nikles S; Pirša M; Justinic D; Zadravec D; Ružić B
    Acta Clin Croat; 2018 Oct; 57(Suppl 1):46-49. PubMed ID: 30457247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.